SPINOVIT

SPINOVIT

Foundation date

24/02/2022

Sector

#Medical Technology

Subsector

• #Medtech - Diagnostic devices

SPINOVIT developed an original method to assess the endothelial dysfunction by measuring a biomarker in a 1 mL blood sample. Our solution consists in a patented syringe and measurement of a biomarker by an innovative technology. This biomarker reveals the quantity of nitric oxide (NO) produced by the endothelial cells. As this production is modulated by the risk factors, our biomarker can so provide information on the real risk exposure of a patient allowing so a personalized medicine approach.

This procedure ensures a safe, minimally invasive and cost-effective method for the patient and an easy, reproducible, evidence-based assessment with an incremental value over standard for the physician.